Skip to main content
Rabigen Mono, süstesuspensioon koertele ja kassidele
  • Trakumsērgas vīruss, celms VP12, Inaktivēts
  • Valid
Authorised in these countries:
  • Estonia

Product identification

Medicine name:
Rabigen Mono, süstesuspensioon koertele ja kassidele
Active substance and strength:
  • Trakumsērgas vīruss, celms VP12, Inaktivēts
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation number:
  • 1364
Product identification number:
  • 176f7991-5685-4e72-afe6-b93b12f21aff
Permanent identification number:
  • 600000062549

Product details

Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat

Availability

Package description:
Manufacturing sites for batch release:
  • Virbac
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • N/A
Date of authorisation status change:
Authorisation country:
  • Estonia
Responsible authority:
  • RAVIMIAMET
Marketing authorisation holder:
  • Virbac
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."